<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27288" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Toxicodendron Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lofgran</surname>
            <given-names>Trevor</given-names>
          </name>
          <aff>West Florida Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahabal</surname>
            <given-names>Gauri D.</given-names>
          </name>
          <aff>Christian Medical College</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Trevor Lofgran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gauri Mahabal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27288.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Plants within the Anacardiaceae family cause Toxicodendron toxicity. It includes plants such as poison ivy, poison oak, poison sumac and is the most common cause of allergic dermatitis in North America. This activity outlines the evaluation and treatment of Toxicodendron toxicity and highlights the interprofessional team's role in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of Toxicodendron toxicity.</p></list-item><list-item><p>Review the appropriate evaluation of Toxicodendron toxicity.</p></list-item><list-item><p>Outline the management options available for Toxicodendron toxicity.</p></list-item><list-item><p>Describe the interprofessional team strategies for improving care coordination and communication to advance Toxicodendron toxicity and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27288&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27288">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27288.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Toxicodendron</italic> is a genus of plants, shrubs, vines, and trees within the Anacardiaceae family. Common names of plants within the family include poison oak, poison ivy, poison sumac, and the Chinese lacquer tree. Many of these names come from similar appearances to other leaves that are non-toxic. The genus as a whole is widespread throughout North America except for Hawaii and Alaska and can have regional variations in appearance. Many of these plants prefer lower elevations and are typically found below 1500 meters. An often-repeated adage regarding their identification is &#x0201c;leaves of three, leave it be,&#x0201d; but it should not be the sole method used. Poison ivy is pervasive throughout North America and has been known to hybridize where its geographic distribution overlaps. Eastern poison ivy (<italic toggle="yes">Toxicodendron radicans</italic>) is commonly found in the eastern half of North America and typically appears as a vine with almond-shaped leaves in groups of three. Leaves change from green to red in the fall. Western or Rydberg&#x02019;s poison ivy (<italic toggle="yes">Toxicodendron rydbergii</italic>) is commonly found as a shrub with small yellow berries. It is distributed throughout much of North America, with the general exception of the Southeastern United States.</p>
        <p>All parts of both plants contain urushiol, which causes characteristic dermatitis associated with exposure. While the genus and its many subspecies have a strong predilection for North America, they can both be found in China, Mexico, Africa, Australia, and New Zealand, to name a few other places. Poison oak has two common variations. Western poison oak (<italic toggle="yes">Toxicodendron diversilobum</italic>) is a deciduous shrub with scalloped or lobed leaves, generally appearing in groups of three that resemble true oak leaves. It is found primarily west of the Rocky Mountains, as the name suggests. While Eastern or Atlantic poison oak (<italic toggle="yes">Toxicodendron pubescens</italic> or <italic toggle="yes">quercifolium</italic>) is frequently confused with Eastern poison ivy as it has three grouped leaves that are structurally similar in appearance. A unique feature useful in identification is the presence of clustered small green fuzzy berries on the plant. Distribution is more common in the Southeastern United States but can extend as far north as New Jersey. The leaves of both western and Atlantic poison oak change colors in the fall time and drop off in the Western species. Poison sumac (<italic toggle="yes">Toxicodendron vernix</italic>) is a deciduous tree or tall shrub found in moist, swampy areas of the eastern United States. It has red stems with a pinnate or feather-like leaf arrangement comprised of 7 to 13 oblong or oval-shaped leaves. The plant also produces green clustering flowers and small globular fruit. The leaves and fruit of the plant are the primary sources of urushiol.</p>
        <p>The Chinese lacquer tree (<italic toggle="yes">Toxicodendron vernicifluum</italic>) is a common deciduous tree in many Asian countries and gets its name for the use of its urushiol-containing sap in lacquer production. Leaves are large and grouped in leaflets of 7&#x000a0;to 19 with flowers that bloom in the summer. All parts of Toxicodendron plants contain urushiol, which is found in sap channeled within the plant. When exposed to air, urushiol turns black and hardens to prevent moisture loss and can be useful in identifying plants in the fall. Urushiol is the primary allergenic cause of contact dermatitis and is typically encountered by brushing up against damaged stems or leaves. Skin exposure results in rapid absorption of the urushiol due to its lipophilic nature.&#x000a0;Names for the toxicity&#x000a0;are variable and include names such as Rhus dermatitis, urushiol-induced contact dermatitis, and Toxicodendron dermatitis.</p>
      </sec>
      <sec id="article-27288.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Toxicodendron dermatitis is the most common cause of allergic contact dermatitis in North America and is caused by skin exposure to urushiol, producing a type IV hypersensitivity reaction.<xref ref-type="bibr" rid="article-27288.r1">[1]</xref>&#x000a0;The chemical structure of urushiol is variable and primarily comprised of catechol with a long hydrocarbon chain.<xref ref-type="bibr" rid="article-27288.r2">[2]</xref><xref ref-type="bibr" rid="article-27288.r3">[3]</xref>&#x000a0;Evidence suggests longer saturated hydrocarbon side chains, the addition of aliphatic side chains and phenolic groups are associated with increasing clinical severity.<xref ref-type="bibr" rid="article-27288.r4">[4]</xref><xref ref-type="bibr" rid="article-27288.r5">[5]</xref>&#x000a0;It is estimated that 50 to 75% of adults are allergic to urushiol.<xref ref-type="bibr" rid="article-27288.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27288.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>A large portion of the population is sensitized to urushiol. Acute allergic dermatitis affects virtually all ages, ethnicities, and skin types, with an estimated 25 to 40 million cases requiring treatment yearly.<xref ref-type="bibr" rid="article-27288.r7">[7]</xref><xref ref-type="bibr" rid="article-27288.r8">[8]</xref>&#x000a0;Occupational exposure is common in forest service workers and comprises many of these cases, with exposure to extremities being more common.<xref ref-type="bibr" rid="article-27288.r8">[8]</xref><xref ref-type="bibr" rid="article-27288.r9">[9]</xref><xref ref-type="bibr" rid="article-27288.r10">[10]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27288.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Acute allergic dermatitis is caused by contact with bruised or broken parts of plants within the <italic toggle="yes">Toxicodendron</italic> species. Urushiol is the primary inciting compound causing the release of local cytokines and inflammatory mediators that initiate the process of sensitization. The compound is rapidly absorbed due to its lipophilic nature and picked up by Langerhans cells in the epidermis, making additional efforts to wash or remove the compound ineffective after absorption.<xref ref-type="bibr" rid="article-27288.r4">[4]</xref>&#x000a0;Initial exposure results in pruritus and erythema, followed by a papulovesicular eruption, edema, and oozing within 10 to 14 days. Symptoms of re-exposure are more acute and appear in 24 to 72 hours.<xref ref-type="bibr" rid="article-27288.r11">[11]</xref>&#x000a0;Aerosolized urushiol from forest fires or burning plant debris has been known to cause airway inflammation or generalized dermatitis in severe cases.</p>
      </sec>
      <sec id="article-27288.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Sensitization and reexposure are mediated by a type IV cell-mediated hypersensitivity reaction.<xref ref-type="bibr" rid="article-27288.r12">[12]</xref><xref ref-type="bibr" rid="article-27288.r13">[13]</xref><xref ref-type="bibr" rid="article-27288.r14">[14]</xref>&#x000a0;Langerhans cells, or antigen-presenting cells (APCs), and other acute inflammatory mediators are activated, initiating a local response. APCs break down urushiol into antigens, which either combine with major histocompatibility complex II (MHC II) or are exposed on the surface of APCs. Transit of Langerhans cells to lymph nodes results in the presentation of the MHC II/antigen complex or free surface antigens to T cell receptors on CD8+ T cells via MHC II or through MHC I on CD4+ T cells, respectively. Clonal expansion then occurs, and subsequent exposure and recognition of antigens by T cells result in repeat allergic dermatitis. While it is estimated that 50 to 75% of adults are allergic to urushiol, variations can occur where T cells cannot recognize the presenting antigens are present, and no immunologic response occurs.<xref ref-type="bibr" rid="article-27288.r6">[6]</xref>&#x000a0;Activation of T cells on initial exposure results in the production of CD4 and CD8 T cells sensitive to urushiol, which then activate a more robust immune response on repeat exposure to the offending agent. Keratinocytes and monocytes also appear to place a role in the release of local cytokines and pro-inflammatory mediators.<xref ref-type="bibr" rid="article-27288.r14">[14]</xref><xref ref-type="bibr" rid="article-27288.r15">[15]</xref><xref ref-type="bibr" rid="article-27288.r16">[16]</xref>&#x000a0;Many of these pathways are the target of corticosteroid treatment.</p>
      </sec>
      <sec id="article-27288.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough history should include any potential occupational and environmental exposure within the past 2 to 3 weeks as initial sensitization may be unknown. Clinicians should be aware of local geographic distributions of the Toxicodendron species. Patients often initially present with complaints of intense pruritis and the beginning stages of a papular or vesicular rash in a linear pattern. Distribution may be scattered as patients often do not recognize exposure until they have contacted other body areas. Black spots may be noted on affected skin or clothing and should be avoided, and it is the result of oxidized urushiol exposed to air.<xref ref-type="bibr" rid="article-27288.r17">[17]</xref><xref ref-type="bibr" rid="article-27288.r18">[18]</xref><xref ref-type="bibr" rid="article-27288.r19">[19]</xref><xref ref-type="bibr" rid="article-27288.r20">[20]</xref>&#x000a0;Secondary exposure can occur when the skin is exposed to oxidized urushiol or animal fur that came in contact with the Toxicodendron species.</p>
      </sec>
      <sec id="article-27288.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A thorough history and physical primarily determine the diagnosis, and no additional testing is required. Allergy patch testing is widely available and may help identify patients with severe urushiol sensitivity, but it is not necessary. It can also increase the risk of sensitization in unsensitized subjects. Dermoscopy, if available,&#x000a0;is another alternative for evaluation of black spot dermatitis caused by Toxicodendron species and would show jagged red-rimmed dark brown lesions.<xref ref-type="bibr" rid="article-27288.r18">[18]</xref></p>
      </sec>
      <sec id="article-27288.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Toxicodendron dermatitis is typically self-limited and resolves within a couple of weeks.<xref ref-type="bibr" rid="article-27288.r1">[1]</xref>&#x000a0;Initial management consists of immediate irrigation with soap and decontamination of clothing upon exposure.<xref ref-type="bibr" rid="article-27288.r4">[4]</xref>&#x000a0;Specific instruction should be given to clean under fingernails as they are commonly missed.<xref ref-type="bibr" rid="article-27288.r21">[21]</xref>&#x000a0;Mild detergents are a reasonable choice when compared to expensive alternatives.<xref ref-type="bibr" rid="article-27288.r22">[22]</xref>&#x000a0;Additional anecdotal options include cool, moist compresses, oatmeal baths, calamine lotion, and topical astringents.<xref ref-type="bibr" rid="article-27288.r7">[7]</xref><xref ref-type="bibr" rid="article-27288.r23">[23]</xref>&#x000a0;A small study comparing topical commercially available cream containing polyethylene granules, sodium lauroyl sarcosinate, nonoxynol-9, C12-15 pareth-9, disodium EDTA, quaternium-15, carbomer (2%), triethanolamine, and water, to placebo showed improvement in symptoms if applied early. Some literature suggests&#x000a0;the use of prophylactic homeopathic oral preparations of poison ivy may be somewhat protective, but randomized controlled trials (RCTs) are lacking.<xref ref-type="bibr" rid="article-27288.r24">[24]</xref>&#x000a0;</p>
        <p>Topical and oral antihistamines are commonly taken medications to decrease pruritus and are typically ineffective outside of their sedative effects as the biochemical process is not due to histamine release. Management should be centered on moderate to high dose topical or systemic corticosteroids that are beneficial early in the disease course, particularly before the appearance of papules or vesicles.<xref ref-type="bibr" rid="article-27288.r25">[25]</xref><xref ref-type="bibr" rid="article-27288.r26">[26]</xref><xref ref-type="bibr" rid="article-27288.r27">[27]</xref>&#x000a0;A tapered dose of prednisone for severe cases can begin at 1 mg/kg/day (0.5 mg/kg/day in pediatric patients) for a max dose of 60mg/day and tapered weekly over three weeks to prevent rebound dermatitis.<xref ref-type="bibr" rid="article-27288.r28">[28]</xref><xref ref-type="bibr" rid="article-27288.r29">[29]</xref>&#x000a0;Alternatives for patients who are not candidates for systemic corticosteroids include applying moderate strength topical corticosteroids with an occlusive dressing for 24 hours that is then repeated 48 hours after initial application.<xref ref-type="bibr" rid="article-27288.r30">[30]</xref>&#x000a0;</p>
        <p>Initial studies assessing the use of topical immunosuppressants for atopic dermatitis were mixed.<xref ref-type="bibr" rid="article-27288.r31">[31]</xref><xref ref-type="bibr" rid="article-27288.r32">[32]</xref>&#x000a0;Newer evidence shows some benefit with the use of tacrolimus and pimecrolimus compared to topical corticosteroids (TCS); however, a meta-analysis of RCTs showed increased adverse events in comparison to TCS.<xref ref-type="bibr" rid="article-27288.r33">[33]</xref>&#x000a0;Both appear to be well tolerated and may play a role in patients who require long-term treatment. While there is considerable interest in developing a vaccine-like compound, current research is ongoing, with the initial phases of clinical trials sound promising.<xref ref-type="bibr" rid="article-27288.r34">[34]</xref>&#x000a0;Although patients typically appear relatively late in the clinical course, care should be taken to actively treat any signs of secondary skin infection with appropriate antibiotics. Excoriations and decreased skin integrity are common etiologies of secondary infections, with the most common pathogen being <italic toggle="yes">Staphylococcus aureus</italic>. Evidence also supports the possibility of polymicrobial infections.<xref ref-type="bibr" rid="article-27288.r35">[35]</xref>&#x000a0;Hyperpigmentation is a possible complication of contact dermatitis in patients with darker skin types and typically resolves within a couple of months.<xref ref-type="bibr" rid="article-27288.r1">[1]</xref></p>
      </sec>
      <sec id="article-27288.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several other conditions may be confused with Toxicodendron toxicity, and a careful history and physical examination are necessary to differentiate between them. Herpes zoster often presents as a vesiculopapular rash but follows a dermatomal pattern that doesn&#x02019;t cross the midline of the body. It is also often preceded by pain in the affected area and would not have a history of environmental exposure. Phytophotodermatitis is another potential mimicker, as it follows a similar timeline. Differentiating factors include plant exposure to sun-exposed areas of the body and the absence of pruritus. Irritant dermatitis is usually sudden in onset and associated with exposure to metals or other irritating compounds with distinct dermal patterns. Other arthropod bites such as bed bugs (<italic toggle="yes">Cimex lectularius</italic>) or scabies (<italic toggle="yes">Sarcoptes scabiei</italic>) may present similarly and be pruritic but lack the appropriate timing and are typically non-vesicular. Scabies has a characteristic burrowing pattern, while bed bug bites tend to have a rapid onset in skin findings.&#x000a0;</p>
      </sec>
      <sec id="article-27288.s11" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Ongoing clinical trials are being performed by the University of Mississippi in conjunction with a biochemical company. Several patents have been issued with regards to vaccine development and initial phase 1 safety studies were completed in 2017.</p>
      </sec>
      <sec id="article-27288.s12" sec-type="Staging">
        <title>Staging</title>
        <p>Presenting symptoms vary in their onset depending upon initial or repeat exposure and consist of a linear appearing papulovesicular eruption of the dermis with erythema and pruritus.<xref ref-type="bibr" rid="article-27288.r12">[12]</xref><xref ref-type="bibr" rid="article-27288.r36">[36]</xref>&#x000a0;As the rash begins to resolve, it is often followed by continued intense pruritis and excoriations. Repeat exposure can last 14 to 21 days, and care should be taken to treat any signs suggestive of secondary infection due to excoriations.<xref ref-type="bibr" rid="article-27288.r7">[7]</xref>&#x000a0;A small subset of the population is hypersensitive to urushiol and presents with rapid onset of widespread symptoms within a few hours. Hyperpigmentation can be a late finding and does not require treatment despite potentially lasting up to several months.</p>
        <p>Toxicodendron dermatitis can be mild, moderate, or severe. Mild cases present mainly with localized or linear erythema and/or edema with minimal symptoms. Moderate to severe cases will have more diffuse involvement associated with severe pain, burning, and/or pruritus.</p>
      </sec>
      <sec id="article-27288.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is largely dependent upon the extent and duration of exposure. Outcomes are typically excellent as management is directed primarily at decreasing innate and adaptive responses. In rare cases of complications or severe exposure, management may be prolonged and require hospital admission.</p>
      </sec>
      <sec id="article-27288.s14" sec-type="Complications">
        <title>Complications</title>
        <p>Uncommon complications include secondary bacterial infection and skin hyperpigmentation. Secondary infections are most commonly due to Staphylococcus aureus or streptococci and should be treated appropriately with additional consideration of concurrent polymicrobial infection.<xref ref-type="bibr" rid="article-27288.r7">[7]</xref> Hyperpigmentation of darker skin types is often self-limited with resolution within months. More severe symptoms&#x000a0;are often associated&#x000a0;with hypersensitive individuals or cases of aerosolized urushiol exposure. These cases should begin with airway assessment and management of any potential signs of anaphylaxis followed by systemic high-dose corticosteroids. In rare circumstances, nephropathy has been reported with Toxicodendron dermatitis.<xref ref-type="bibr" rid="article-27288.r37">[37]</xref></p>
      </sec>
      <sec id="article-27288.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be counseled regarding the identification of local <italic toggle="yes">Toxicodendron</italic> species and avoidance. If occupational exposure is encountered, proper protective equipment should be outlined with specific instructions to use vinyl gloves as urushiol can penetrate rubber or latex gloves.<xref ref-type="bibr" rid="article-27288.r8">[8]</xref>&#x000a0;As part of decontamination, all clothing and objects with potential exposure should be cleaned with warm water and detergents. There is evidence to alternatively support the use of bentonite, and other commercially available organoclay barrier creams, prior to exposure.<xref ref-type="bibr" rid="article-27288.r38">[38]</xref><xref ref-type="bibr" rid="article-27288.r39">[39]</xref>&#x000a0;Current evidence does not support the use of desensitization programs.<xref ref-type="bibr" rid="article-27288.r40">[40]</xref><xref ref-type="bibr" rid="article-27288.r41">[41]</xref><xref ref-type="bibr" rid="article-27288.r42">[42]</xref></p>
      </sec>
      <sec id="article-27288.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The best prevention of <italic toggle="yes">Toxicodendron</italic> dermatitis is avoidance, followed by appropriate barriers and decontamination. Regional variations in plant structure often make identification challenging, making misidentification the most common pitfall. Poison ivy comprises a large percentage of exposures throughout North America and is the most commonly misidentified species.<xref ref-type="bibr" rid="article-27288.r43">[43]</xref>&#x000a0;Key points in the identification of poison ivy include leaves that are found in groups of three without the presence of thorns or jagged/scalloped edges. Management of exposure should begin by immediately washing affected skin with soap and water and early application of topical corticosteroids. In severe cases or where there is respiratory system involvement, hospital admission may be necessary. Of special note, several other species within the cashew/sumac family or Anacardiaceae have cross-reactivity with urushiol sensitized patients. Some of the more commonly known causes include exposure to the fruit or trees of mangos, cashew nuts, and ginkgo biloba.<xref ref-type="bibr" rid="article-27288.r44">[44]</xref><xref ref-type="bibr" rid="article-27288.r45">[45]</xref></p>
      </sec>
      <sec id="article-27288.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Communication between physicians and other professionals, acting as an interprofessional team, is essential in managing these patients as they may present in a variety of clinical settings. This healthcare team will consist of clinicians, mid-level practitioners, nurses, and pharmacists, working collaboratively to achieve optimal patient outcomes. [Level 5]</p>
        <p>Management should be followed primarily by a primary care provider or dermatologist as the mainstay of treatment is corticosteroids, which have many potential side effects. Evidence supporting the use of corticosteroids or other topical immunosuppressives is well documented and supported by a meta-analysis of randomized controlled trials (RCT). [Level 1] Knowledge and understanding of management by nurses and pharmacists is also critical as they tend to be more readily accessible to patients and should be knowledgeable regarding potential complications and management. Outcomes are typically excellent with or without treatment, and patients should be given specific instructions regarding prevention, decontamination, and when to return if symptoms spread or worsen. [Level 4]</p>
        <p>If there is a concern for systemic or respiratory exposure, patients should be admitted to the hospital for further observation and management.</p>
      </sec>
      <sec id="article-27288.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27288&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27288">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/toxicodendron-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27288">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27288/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27288">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27288.s19">
        <title>References</title>
        <ref id="article-27288.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Poison ivy/oak/sumac. Part II: Specific features.</article-title>
            <source>Cutis</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-4</page-range>
            <pub-id pub-id-type="pmid">8823544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DAWSON</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>The chemistry of poison ivy.</article-title>
            <source>Trans N Y Acad Sci</source>
            <year>1956</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>427</fpage>
            <page-range>427-43</page-range>
            <pub-id pub-id-type="pmid">13312069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SYMES</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>DAWSON</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Separation and structural determination of the olefinic components of poison ivy urushiol, cardanol and cardol.</article-title>
            <source>Nature</source>
            <year>1953</year>
            <month>May</month>
            <day>09</day>
            <volume>171</volume>
            <issue>4358</issue>
            <fpage>841</fpage>
            <page-range>841-2</page-range>
            <pub-id pub-id-type="pmid">13054743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGovern</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Barkley</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Botanical dermatology.</article-title>
            <source>Int J Dermatol</source>
            <year>1998</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>321</fpage>
            <page-range>321-34</page-range>
            <pub-id pub-id-type="pmid">9620476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoner</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Plant dermatitis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1983</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-15</page-range>
            <pub-id pub-id-type="pmid">6886091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Flamm</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>ElSohly</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Hage</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hamann</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?</article-title>
            <source>Dermatitis</source>
            <year>2019</year>
            <season>May/Jun</season>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>183</fpage>
            <page-range>183-190</page-range>
            <pub-id pub-id-type="pmid">31045932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baer</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Poison ivy dermatitis.</article-title>
            <source>Cutis</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-6</page-range>
            <pub-id pub-id-type="pmid">2143465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Epstein</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Occupational poison ivy and oak dermatitis.</article-title>
            <source>Dermatol Clin</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>511</fpage>
            <page-range>511-6</page-range>
            <pub-id pub-id-type="pmid">7923948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oltman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hensler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Poison oak/ivy and forestry workers.</article-title>
            <source>Clin Dermatol</source>
            <year>1986</year>
            <season>Apr-Jun</season>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-6</page-range>
            <pub-id pub-id-type="pmid">2941133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rademaker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Duffill</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Allergic contact dermatitis to Toxicodendron succedaneum (rhus tree): an autumn epidemic.</article-title>
            <source>N Z Med J</source>
            <year>1995</year>
            <month>Apr</month>
            <day>12</day>
            <volume>108</volume>
            <issue>997</issue>
            <fpage>121</fpage>
            <page-range>121-3</page-range>
            <pub-id pub-id-type="pmid">7739818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Individual variations in allergic contact dermatitis from urushiol.</article-title>
            <source>Arch Dermatol</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>135</volume>
            <issue>8</issue>
            <fpage>1002</fpage>
            <page-range>1002-3</page-range>
            <pub-id pub-id-type="pmid">10456367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gladman</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Toxicodendron dermatitis: poison ivy, oak, and sumac.</article-title>
            <source>Wilderness Environ Med</source>
            <year>2006</year>
            <season>Summer</season>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-8</page-range>
            <pub-id pub-id-type="pmid">16805148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Benezra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burrows</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Camarasa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dooms-Goossens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ducombs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frosch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lachapelle</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lahti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Menn&#x000e9;</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Contact dermatitis. A review.</article-title>
            <source>Contact Dermatitis</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>55</fpage>
            <page-range>55-78</page-range>
            <pub-id pub-id-type="pmid">3552400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalish</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Recent developments in the pathogenesis of allergic contact dermatitis.</article-title>
            <source>Arch Dermatol</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>127</volume>
            <issue>10</issue>
            <fpage>1558</fpage>
            <page-range>1558-63</page-range>
            <pub-id pub-id-type="pmid">1929465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Role of keratinocytes in allergic contact dermatitis.</article-title>
            <source>Contact Dermatitis</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-8</page-range>
            <pub-id pub-id-type="pmid">1505178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kupper</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Production of cytokines by epithelial tissues. A new model for cutaneous inflammation.</article-title>
            <source>Am J Dermatopathol</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-73</page-range>
            <pub-id pub-id-type="pmid">2644870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurlan</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Black spot poison ivy: A report of 5 cases and a review of the literature.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>246</fpage>
            <page-range>246-9</page-range>
            <pub-id pub-id-type="pmid">11464186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rader</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Mu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stoecker</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Hinton</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy of black-spot poison ivy.</article-title>
            <source>Dermatol Online J</source>
            <year>2012</year>
            <month>Oct</month>
            <day>15</day>
            <volume>18</volume>
            <issue>10</issue>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">23122015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haitz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mikailov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Black linear streaks on the face with pruritic plaques on the trunk and arms.</article-title>
            <source>Cutis</source>
            <year>2017</year>
            <month>May</month>
            <volume>99</volume>
            <issue>5</issue>
            <fpage>E5</fpage>
            <page-range>E5-E6</page-range>
            <pub-id pub-id-type="pmid">28632804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pittman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Black spot poison ivy: under the cover of darkness.</article-title>
            <source>J Emerg Med</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>e331</fpage>
            <page-range>e331-2</page-range>
            <pub-id pub-id-type="pmid">23419214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanner</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Rhus (Toxicodendron) dermatitis.</article-title>
            <source>Prim Care</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>493</fpage>
            <page-range>493-502</page-range>
            <pub-id pub-id-type="pmid">10815057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stibich</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Yagan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Herndon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Cost-effective post-exposure prevention of poison ivy dermatitis.</article-title>
            <source>Int J Dermatol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>515</fpage>
            <page-range>515-8</page-range>
            <pub-id pub-id-type="pmid">10940115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williford</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Sheretz</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Poison ivy dermatitis. Nuances in treatment.</article-title>
            <source>Arch Fam Med</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>184</fpage>
            <page-range>184-8</page-range>
            <pub-id pub-id-type="pmid">7994440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cury Martins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gois</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Topical tacrolimus for atopic dermatitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Jul</month>
            <day>01</day>
            <volume>2015</volume>
            <issue>7</issue>
            <fpage>CD009864</fpage>
            <pub-id pub-id-type="pmid">26132597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vernon</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>5 Pt 1</issue>
            <fpage>829</fpage>
            <page-range>829-32</page-range>
            <pub-id pub-id-type="pmid">2147698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodall</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Oral corticosteroids for poison ivy dermatitis.</article-title>
            <source>CMAJ</source>
            <year>2002</year>
            <month>Feb</month>
            <day>05</day>
            <volume>166</volume>
            <issue>3</issue>
            <fpage>300</fpage>
            <page-range>300-1</page-range>
            <pub-id pub-id-type="pmid">11868634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moe</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>How much steroid for poison ivy?</article-title>
            <source>Postgrad Med</source>
            <year>1999</year>
            <month>Oct</month>
            <day>01</day>
            <volume>106</volume>
            <issue>4</issue>
            <fpage>21</fpage>
            <page-range>21, 24</page-range>
            <pub-id pub-id-type="pmid">10533503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brodell</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Taking the itch out of poison ivy. Are you prescribing the right medication?</article-title>
            <source>Postgrad Med</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>106</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-70</page-range>
            <pub-id pub-id-type="pmid">10418575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wooldridge</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>Acute allergic contact dermatitis. How to manage severe cases.</article-title>
            <source>Postgrad Med</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>221</fpage>
            <page-range>221-4</page-range>
            <pub-id pub-id-type="pmid">2138290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guin</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Treatment of toxicodendron dermatitis (poison ivy and poison oak).</article-title>
            <source>Skin Therapy Lett</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>3</fpage>
            <page-range>3-5</page-range>
            <pub-id pub-id-type="pmid">11376396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashcroft</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Dimmock</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garside</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.</article-title>
            <source>BMJ</source>
            <year>2005</year>
            <month>Mar</month>
            <day>05</day>
            <volume>330</volume>
            <issue>7490</issue>
            <fpage>516</fpage>
            <pub-id pub-id-type="pmid">15731121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amrol</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Keitel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hagaman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Topical pimecrolimus in the treatment of human allergic contact dermatitis.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>91</volume>
            <issue>6</issue>
            <fpage>563</fpage>
            <page-range>563-6</page-range>
            <pub-id pub-id-type="pmid">14700441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ab&#x00119;d&#x0017a;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pawliczak</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>752</fpage>
            <page-range>752-759</page-range>
            <pub-id pub-id-type="pmid">31998006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baldwin</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Clegg</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Curran</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hudecz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Lepoittevin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.</article-title>
            <source>Arch Dermatol Res</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>291</volume>
            <issue>12</issue>
            <fpage>652</fpage>
            <page-range>652-8</page-range>
            <pub-id pub-id-type="pmid">10651166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brook</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Frazier</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Yeager</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Microbiology of infected poison ivy dermatitis.</article-title>
            <source>Br J Dermatol</source>
            <year>2000</year>
            <month>May</month>
            <volume>142</volume>
            <issue>5</issue>
            <fpage>943</fpage>
            <page-range>943-6</page-range>
            <pub-id pub-id-type="pmid">10809852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Arriola</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Poison ivy, oak, and sumac dermatitis.</article-title>
            <source>West J Med</source>
            <year>1999</year>
            <season>Nov-Dec</season>
            <volume>171</volume>
            <issue>5-6</issue>
            <fpage>354</fpage>
            <page-range>354-5</page-range>
            <pub-id pub-id-type="pmid">10639874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devich</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Spitler</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Hopper</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Renal lesions accompanying poison oak dermatitis.</article-title>
            <source>Clin Nephrol</source>
            <year>1975</year>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>106</fpage>
            <page-range>106-13</page-range>
            <pub-id pub-id-type="pmid">124640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Sheretz</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Rietschel</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>2 Pt 1</issue>
            <fpage>212</fpage>
            <page-range>212-6</page-range>
            <pub-id pub-id-type="pmid">7622647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grevelink</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>2 Pt 1</issue>
            <fpage>182</fpage>
            <page-range>182-8</page-range>
            <pub-id pub-id-type="pmid">1430354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Trautlein</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Laws</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Sicard</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Oral hyposensitization to poison ivy and poison oak.</article-title>
            <source>Arch Dermatol</source>
            <year>1987</year>
            <month>Apr</month>
            <volume>123</volume>
            <issue>4</issue>
            <fpage>476</fpage>
            <page-range>476-8</page-range>
            <pub-id pub-id-type="pmid">2950827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Epstein</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Frankart</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Induction of antigen specific hyposensitization to poison oak in sensitized adults.</article-title>
            <source>Arch Dermatol</source>
            <year>1982</year>
            <month>Sep</month>
            <volume>118</volume>
            <issue>9</issue>
            <fpage>630</fpage>
            <page-range>630-3</page-range>
            <pub-id pub-id-type="pmid">6180687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Poison ivy/oak dermatitis. Part I: Prevention--soap and water, topical barriers, hyposensitization.</article-title>
            <source>Cutis</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>384</fpage>
            <page-range>384-6</page-range>
            <pub-id pub-id-type="pmid">8804839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGovern</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>LaWarre</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Brunette</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Is it, or isn't it? Poison ivy look-a-likes.</article-title>
            <source>Am J Contact Dermat</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-10</page-range>
            <pub-id pub-id-type="pmid">10908180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hershko</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ingber</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis.</article-title>
            <source>Contact Dermatitis</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-5</page-range>
            <pub-id pub-id-type="pmid">15701120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27288.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Carius</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Mango Dermatitis After Urushiol Sensitization.</article-title>
            <source>Clin Pract Cases Emerg Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>361</fpage>
            <page-range>361-363</page-range>
            <pub-id pub-id-type="pmid">31763588</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
